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A B S T R A C T
Background: The literature suggests an association between type 2 diabetes mellitus and depression, but data on
the association between gestational diabetes mellitus (GDM) and postpartum depressive symptomatology (PPDS)
are scarce.
Methods: Altogether, 1066 women with no previous mental health issues enrolled in the Kuopio Birth Cohort
(KuBiCo, www.kubico.ﬁ) were selected for this study. GDM was diagnosed according to the Finnish Current Care
Guidelines. Depressive symptomatology was assessed with the Edinburgh Postnatal Depression Scale (EPDS)
during the third trimester of pregnancy and eight weeks after delivery. Additionally, a subgroup of women
(n=505) also completed the EPDS during the ﬁrst trimester of pregnancy.
Results: The prevalence rates of GDM and PPDS in the whole study population were 14.1% and 10.3%, re-
spectively. GDM was associated with an increased likelihood of belonging to the PPDS group (OR 2.23, 95% CI
1.23–4.05; adjusted for maternal age at delivery, BMI in the ﬁrst trimester, smoking before pregnancy, re-
lationship status, nulliparity, delivery by caesarean section, gestational age at delivery, neonatal intensive care
unit admission and third-trimester EPDS scores). A signiﬁcant association between GDM and PPDS was found in
the subgroup of women with available data on ﬁrst-trimester depression (n=505).
Limitations: The participation rate of the KuBiCo study was relatively low (37%).
Conclusions: Women with GDM may be at increased risk of PPDS. Future studies should investigate whether
these women would beneﬁt from a closer follow-up and possible supportive interventions during pregnancy and
the postpartum period to avoid PPDS.
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1. Introduction
Gestational diabetes mellitus (GDM) and postpartum depression
(PPD) are both highly prevalent in perinatal conditions. In Finland,
during the last ﬁve years, the 12-month prevalence of GDM has been
reported to be approximately 9–13% (National Institute of Health and
Welfare, 2016), and worldwide, the respective ﬁgures have been as
high as 17.8% (Coustan et al., 2010). Nevertheless, the prevalence of
GDM has varied in the literature due to inconsistent diagnostic criteria
and study populations (Mcintyre et al., 2015). GDM usually develops
before the third trimester of pregnancy, and is caused by insuﬃcient
secretion of insulin with respect to overt gestational insulin resistance, a
physiological condition that all pregnant women develop to some de-
gree (Buchanan and Xiang, 2005). Furthermore, approximately 10–15%
of all mothers are aﬀected by PPD (Patel et al., 2012). PPD represents a
possible risk to a healthy mother–baby relationship, and may thus have
a signiﬁcant impact on infant development (Tronick and Reck, 2009).
Several potential risk factors for PPD have been identiﬁed, such as a
history of depression before pregnancy, depression or anxiety during
pregnancy and poor social support (O'Hara and McCabe, 2013). Fur-
thermore, obesity at the beginning of pregnancy has been suggested to
increase the likelihood of PPD (Molyneaux et al., 2014), and PPD has
been suggested to be a preface to a chronic depressive disorder
(Vliegen et al., 2014). In turn, high pre-pregnancy BMI and excessive
weight gain during early pregnancy are associated with a signiﬁcantly
increased risk of GDM (Morisset et al., 2010; Robitaille, 2015). Women
with GDM are also at greater risk of developing type 2 diabetes mellitus
later in life (Bellamy et al., 2009).
In the general population, people with type 2 diabetes mellitus have
a 21% greater risk of experiencing depressive symptoms than those
without type 2 diabetes (Nouwen et al., 2010). Conversely, people with
a diagnosis of depression or with depressive symptoms have a 1.4-fold
greater risk of developing type 2 diabetes mellitus than non-diagnosed
or asymptomatic individuals (Knol et al., 2006). Furthermore, an as-
sociation between a medical history of depression and an increased
likelihood of developing GDM has been suggested based on a large
multi-ethnic retrospective cohort study in the US (Bowers et al., 2013).
Nevertheless, data on the relationship between GDM and PPD remain
scarce.
A recent population-based study has suggested an association be-
tween GDM and a subsequent diagnosis of depression within the ﬁrst
year after delivery (Silverman et al., 2017). The diagnostic criteria for
GDM were not reported as part of this study (Silverman et al., 2017).
Furthermore, a prospective cohort study suggested an association be-
tween GDM and postpartum depressive symptomatology (PPDS) at six
weeks after delivery (Hinkle et al., 2016). However, no signiﬁcant as-
sociation between GDM and PPDS at six months after delivery was
detected in another recent study (Huang et al., 2015). Nevertheless, this
study used diﬀerent diagnostic criteria for GDM compared to our study
(Huang et al., 2015).
Thus, we sought to clarify the association between GDM and PPDS
in a prospective setting, using GDM diagnostic criteria closely resem-
bling the established International Association of Diabetes and
Pregnancy Study Groups criteria for GDM. Based on the few previous
epidemiological observations and the similar adverse immunological
changes in both GDM and PPDS (Osborne and Monk, 2013), we hy-
pothesized that GDM would be associated with an increased likelihood
of belonging to the group with PPDS compared to the group with no
PPDS.
2. Methods
2.1. Study sample
This study was conducted as a part of the ongoing Kuopio Birth
Cohort (KuBiCo; www.kubico.ﬁ) Study. The KuBiCo Study was initiated
in 2012, with a target of collecting data from a total of 10,000 mo-
ther–child pairs until the child reaches the age of 18 years. All women
who are expected to give birth at Kuopio University Hospital based on
their place of residence are invited to participate in the study. To date,
the participation rate has been approximately 37%. The research ethics
committee of the Central Finland Health Care District has approved the
KuBiCo study (8.12.2011, K-S SHP Dnro 18U/2011).
The sample used in this study was extracted from the KuBiCo da-
tabase in January 2017 (n=4145) and included all pregnancies that
had complete Edinburgh Postnatal Depression Scale (EPDS) data in the
postpartum phase (n=1917). Of these pregnancies, the ﬁnal sample
consisted of a total of 1066 women after the exclusion of later preg-
nancies of women who provided more than one case (n=50) and those
women with previous mental health issues (n=174), a previous di-
agnosis of diabetes mellitus (n=38), multiple pregnancy (n=19),
missing information on EPDS in the third trimester of pregnancy
(n=652), missing information on age (n=4) or missing information
on BMI in the ﬁrst trimester (n=9). Data on previous diagnoses of
diabetes mellitus were based on self-reports in cases of type I diabetes
(n=19), type II diabetes (n=7) and GDM in previous pregnancies
(n=5). In the case of self-reports of undeﬁned types of diabetes
(n=7), the diagnoses were checked from hospital records to distin-
guish between previously diagnosed diabetes and current GDM. Data on
multiple pregnancies were retrieved from hospital records, and the
previous mental health issues were either self-reported as a part of
routine Finnish prenatal care as “previous mental health issues / psy-
chiatric disorder” (n=156) or based on the self-reported earlier use of
psychotropic medication (n=66). In attrition analysis, no diﬀerences
were detected between the group excluded from the original sample
and the group with full available data either in the mean ranks of BMI
in the ﬁrst trimester (means: ﬁnal sample 24.8 kg/m2 vs. excluded
24.9 kg/m2; Z= –0.4, p=0.674) or in the mean ranks of maternal age
at delivery (means: ﬁnal sample 30.1 years vs. excluded 29.9 years;
Z= –0.7, p=0.481). Of the ﬁnal sample, a sub-group of 505 women
had also completed the EPDS during the ﬁrst trimester of pregnancy,
and they were included in the secondary analyses.
2.2. Gestational diabetes mellitus
GDM was diagnosed according to Finnish clinical guidelines as a
routine procedure, on average during pregnancy weeks 24–28 (Finnish
Current Care Guidelines, www.kaypahoito.ﬁ). All participants under-
went an oral glucose tolerance test (OGTT), with the following two
exceptions deﬁned by the clinical guidelines: 1) young (< 25 years)
nulliparous women with BMI< 25 kg/m2 whose close relatives (sib-
lings, parents or grandparents) had not had type 2 diabetes mellitus
(American Diabetes Association, 2007) and 2) multiparous women
under 40 years of age and with BMI< 25 kg/m2 whose earlier preg-
nancies had been free from GDM and foetal macrosomia (Lu et al.,
2002). For the above exceptions, as well as for individuals with normal
earlier OGTT values, an OGTT was in some cases performed or repeated
later during pregnancy due to some other clinical GDM risk indicators,
such as excessive maternal weight gain or foetal growth, or an increased
amount of amniotic ﬂuid. In our study population, 79% of the women
underwent an OGTT during some stage of their pregnancy, and 20% of
the women underwent the test twice. The OGTT was administered in
the morning after a 12-hour fast. In the OGTT, a venous blood sample is
taken before drinking 300ml of water containing 75 g of glucose within
ﬁve minutes. Second and third venous blood samples are taken one and
two hours after ingesting the test liquid. Diagnostic thresholds for ele-
vated plasma glucose concentrations are as follows: 5.3mmol/l for the
fasting stage, 10.0 mmol/l for 1 h after ingesting the test liquid and
8.6 mmol/l for 2 hours after ingesting the test liquid. Meeting or ex-
ceeding at least one of the above set values is considered diagnostic for
GDM. The diagnoses of GDM were retrieved from hospital diagnosis
records.
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2.3. Depression
Third-trimester depressive symptomatology and postpartum de-
pressive symptomatology (PPDS) were assessed with the EPDS, which is
completed online between weeks 28 and 44 of pregnancy and eight
weeks after delivery. Additionally, a total of 505 women also completed
the EPDS during the ﬁrst trimester between pregnancy weeks 6 and 13.
The EPDS is a 10-item questionnaire with four response options for each
question. Each answer is scored on a scale of 0–3 points, and the ﬁnal
scale score ranges between 0 and 30. A cut-oﬀ of 10 points or more was
used to identify women with depressive symptomatology (Cox et al.,
1987). In this article, we use the depressive symptomatology cut-oﬀ to
deﬁne ﬁrst-trimester depressive symptomatology, third-trimester de-
pressive symptomatology and PPDS.
2.4. Covariates
Based on previous literature on the risk factors for both GDM and
PPD, covariates for our models included: maternal age at delivery
(continuous) (Reid and Meadows-Oliver, 2007), BMI (kg/m2) in the
ﬁrst trimester (continuous) (Molyneaux et al., 2014), the relationship
status (living with a partner vs. not living with a partner)
(Dørheim et al., 2009), nulliparity (yes/no) (Räisänen et al., 2013) and
smoking before pregnancy (smoked one or more cigarettes per day vs.
zero cigarettes per day) (Lasser et al., 2000), collected with a back-
ground questionnaire completed online by the mothers in the ﬁrst tri-
mester of their pregnancy. Additional covariates consisted of gesta-
tional age at delivery (weeks) (Räisänen et al., 2013), mode of delivery
(vaginal or caesarean delivery) (Räisänen et al., 2013) and the need for
neonatal intensive care unit (NICU) admission (Blom et al., 2010), as
entered by a nurse into an electronic database on the delivery ward at
Kuopio University Hospital.
2.5. Statistical methods
Univariate diﬀerences between women with and without GDM were
evaluated using the chi-squared test for dichotomous variables and
Mann–Whitney U-test for continuous variables due to their non-normal
distribution. Normality was assessed with a normal Q–Q plot and his-
togram visualisation. In order to examine the possible mediator role of
the covariates, we also determined univariate diﬀerences between the
PPDS group and the non-PPDS group using the chi-squared test for
dichotomous variables and Mann–Whitney U-test for continuous vari-
ables.
2.5.1. Multivariable analyses for the whole study population
To investigate the eﬀect of potential confounders on the observed
associations between GDM and PPDS, we utilised logistic regression
analysis (method: enter). After determining the crude OR, three dif-
ferent models were constructed. Model 1 included maternal age at
delivery and BMI in the ﬁrst trimester. Model 2 included all the vari-
ables in the study except for third-trimester EPDS scores (i.e., maternal
age at delivery, BMI in the ﬁrst trimester, smoking before pregnancy,
relationship status, nulliparity, delivery by caesarean section, gesta-
tional age at delivery and NICU admission). Model 3 was Model 2
further adjusted for third-trimester EPDS scores.
2.5.2. Multivariable analyses for the subgroup of women with complete
ﬁrst-trimester EPDS data
Separate logistic regression analyses were performed in the sub-
group of women who also completed the EPDS during the ﬁrst trimester
of pregnancy. In order to avoid overﬁtting, among this subgroup, the
maximum number of covariates was limited to 5, i.e. to 10% or less of
the number of subjects in the smallest group under observation (PPDS
group, n=50) (Babyak, 2004). Thus, for these analyses, Model 4 was
Model 1 (maternal age at delivery and ﬁrst trimester BMI) further ad-
justed for ﬁrst-trimester EPDS scores, and Model 5 was Model 4 further
adjusted for third-trimester EPDS scores.
All the statistical tests were two-tailed, with the alpha level set to
0.05. IBM SPSS Statistics Version 24 was used to analyse the data.
3. Results
3.1. All participants
In the whole study population (n=1066), the prevalence rates of
GDM and PPDS were 14.1% (n=150) and 10.3% (n=110), respec-
tively. Women with GDM had a higher prevalence of PPDS and the
mode of delivery was more often caesarean section compared to women
with no GDM (Table 1). Women in the GDM group were also older and
their BMI in the ﬁrst trimester was higher than among women in the
non-GDM group. Among women with GDM, the gestational age at de-
livery was lower than among those with no GDM.
Furthermore, of the women with PPDS, 40.9% (n=45) had third-
trimester depressive symptomatology. In the whole sample, the pre-
valence of third-trimester depressive symptomatology was 9.5%
(n=101) (of these women, 44.6% (n=45) subsequently developed
PPDS). GDM was not associated with an increased likelihood of third-
trimester depressive symptomatology (OR 0.89, 95% CI 0.49–1.64).
Of the covariates included in the analyses, four lay chronologically
between the GDM diagnosis and the PPDS measurement (i.e., third-
trimester depressive symptomatology, gestational age, caesarean sec-
tion and NICU admission). However, only caesarean section and ge-
stational age were in fact associated with GDM (Table 1), thus implying
their possible role as mediators. However, this possibility was ruled out,
as these variables were not associated with PPDS (prevalence of PPDS
Table 1
Characteristics of the study population in relation to gestational diabetes mellitus.
GDM=no (n=916, 85.9%) GDM=yes (n=150, 14.1%) Test value p-value
n (%)
Postpartum depressive symptomatology 86 (9.4) 24 (16.0) χ2= 6.1 0.014a
Caesarean section 86 (9.4) 23 (15.3) χ2= 5.0 0.026a
Neonatal intensive care unit admission 86 (9.4) 19 (12.7) χ2= 1.6 0.212a
Nulliparous 512 (55.9) 71 (47.3) χ2= 3.8 0.051a
Smoking before pregnancy 121 (13.2) 16 (10.7) χ2= 0.7 0.388a
Living with a partner 335 (36.6) 54 (36.0) χ2= 0.02 0.893a
Third-trimester depressive symptomatology 88 (9.6) 13 (8.7) χ2= 0.1 0.715a
Mean (SD)
BMI in the ﬁrst trimester (kg/m2) 24.1 (4.3) 28.7 (6.5) Z= –8.8 <0.001b
Maternal age at delivery (years) 29.9 (4.9) 31.4 (5.4) Z= –3.3 0.001b
Gestational age at delivery (weeks) 39.6 (1.5) 39.3 (1.4) Z= –2.5 0.011b
a Chi-squared test.
b Mann–Whitney U-test.
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in caesarean section group vs. vaginal delivery group: 10.1% vs. 10.3%,
χ2= 0.01; p=0.934; mean gestational age in non-PPDS vs. PPDS
group: 39.5 weeks vs. 39.7 weeks, Z= –0.8, p=0.420). In the multi-
variable analysis, GDM was associated with a 1.7-fold higher likelihood
of belonging to the group with PPDS (adjusted for maternal age at
delivery and BMI in the ﬁrst trimester: OR 1.70, 95% CI 1.00–2.89)
(Table 2). This association remained signiﬁcant in all further adjust-
ment models and was most robust in Model 3, which included all the
available covariates (OR 2.23, 95% CI 1.23–4.05).
3.2. Women with complete ﬁrst-trimester EPDS data
In the subgroup of women who completed the EPDS during the ﬁrst
trimester (n=505), the prevalence rates of GDM and depressive
symptomatology were as follows: GDM 14.7% (n=74), ﬁrst-trimester
depressive symptomatology 7.5% (n=38), third-trimester depressive
symptomatology 8.1% (n=41) and PPDS 9.9% (n=50). In this sub-
group, of the women with PPDS, 26.0% (n=13) had ﬁrst-trimester
depressive symptomatology, 36.0% (n=18) had third-trimester de-
pressive symptomatology, 48.0% (n=24) had either ﬁrst-trimester or
third-trimester depressive symptomatology, or both, and 14.0% (n=7)
had both ﬁrst-trimester and third-trimester depressive symptoma-
tology. Neither ﬁrst-trimester depressive symptomatology (OR 0.48,
95% CI 0.14–1.60) nor third-trimester depressive symptomatology (OR
1.00, 95% CI 0.40–2.46) was associated with an increased likelihood of
belonging to the GDM group. The crude association between GDM and
PPDS was signiﬁcant in the chi-squared test (prevalence of PPDS in non-
GDM group vs. GDM group: 8.8% vs. 16.2%, χ2= 3.9, p=0.049) and
nearly signiﬁcant in unadjusted logistic regression analysis (OR: 2.00,
95% CI 0.99–4.04) (Table 3). However, the association was no longer
signiﬁcant after adjusting for maternal age at delivery and BMI in the
ﬁrst trimester alone (Model 1): OR 1.82, 95% CI 0.86–3.87. Never-
theless, the association between GDM and an increased likelihood of
belonging to the PPDS group remained signiﬁcant in all further ad-
justment models and was most robust in Model 5, which included
maternal age at delivery, BMI in the ﬁrst trimester, ﬁrst-trimester EPDS
scores and third-trimester EPDS scores as covariates (OR 2.43, 95% CI
1.05–5.62).
4. Discussion
4.1. Main ﬁndings
We observed an association between GDM and a higher risk of
PPDS, irrespective of third-trimester depressive symptomatology.
Furthermore, among the subgroup of women with complete EPDS data
for both ﬁrst and third trimesters, ﬁrst-trimester depressive sympto-
matology was not associated with an elevated risk of subsequent GDM,
and the observation of an association between GDM and a higher risk of
PPDS was signiﬁcant when controlling for ﬁrst-trimester depressive
symptomatology.
4.2. Comparison with previous literature
Our ﬁnding of an association between a diagnosis of GDM and a
higher risk of PPDS is consistent with the results of a prospective cohort
study in the US (Hinkle et al., 2016), a population-based prospective
cohort study in Sweden (Silverman et al., 2017) and a longitudinal
cohort study in an Iranian population (Abdollahi et al., 2014). The US
study used diﬀerent diagnostic criteria (i.e., the Carpenter and Coustan
criteria (Mcintyre et al., 2015)) compared with the present study. This
resulted in a noticeable diﬀerence in the prevalence of GDM between
the US study group and the present study group (4.3% vs. 14.1%, re-
spectively). Furthermore, the US study found an association between
depressive symptomatology in early pregnancy and an increased risk of
GDM, whereas in our study, ﬁrst-trimester depressive symptomatology
was not associated with an increased likelihood of subsequent GDM.
Nevertheless, the GDM criteria were not speciﬁed in either the Swedish
study or the Iranian study, and the observations derived from these
studies were not controlled for maternal BMI at the beginning of
pregnancy, a crucial potential confounding factor.
Despite the above ﬁndings being in line with our observations, ﬁve
other studies have found no associations between GDM and PPD/PPDS
(Huang et al., 2015; Kim et al., 2005; Liu and Tronick, 2013; Meltzer-
Brody et al., 2017; Miller et al., 2016). However, it is notable that the
only one of these ﬁve studies to specify the diagnostic criteria for GDM
used the two-step method recommended by the American Diabetes
Association (Huang et al., 2015). The diﬀerence in GDM prevalence
between the study groups in this US longitudinal study (Huang et al.,
2015) and in the current study (5.2% vs. 14.1%, respectively) is in line
with that reported in a study comparing the two-step approach criteria
with the IADPSG criteria (6% with the two-step approach vs. 14.5%
with the IADPSG criteria) (Sevket et al., 2014). Thus, it remains un-
certain whether it is possible to compare the longitudinal US study
(Huang et al., 2015) with our study, considering the noticeable diﬀer-
ence in the criteria used to diagnose GDM. However, one of the ﬁve
studies with no observed association between GDM and PPD/PPDS
found an association between GDM and the postpartum acute stress
reaction (Meltzer-Brody et al., 2017). Moreover, one cross-sectional
study examined the relationship between GDM and PPDS in two eth-
nically diﬀerent populations: an association was observed among Qatari
women, while no such association was observable among other Arab
women (Burgut et al., 2013). Unfortunately, no information on the
maternal BMI or the diagnostic criteria of GDM was available for this
study (Burgut et al., 2013).
4.3. Possible mechanisms
Psychological factors may at least partly explain the observed as-
sociation between GDM and PPDS. The diagnosis of GDM may be
considered as a stressful life event, which itself is an established risk
Table 2
Likelihood of women with a diagnosis of gestational diabetes mellitus be-
longing to the group with postpartum depressive symptomatology in logistic
regression models performed in the whole study population (n=1066).
Odds ratio 95% Conﬁdence interval p-value
Unadjusted 1.84 1.13–3.00 0.015
Model 1 1.70 1.00–2.89 0.048
Model 2 1.83 1.08–3.11 0.026
Model 3 2.23 1.23–4.05 0.008
Model 1 is adjusted for maternal age at delivery and BMI in the ﬁrst trimester.
Model 2 is Model 1 further adjusted for smoking before pregnancy, living with a
partner, nulliparity, gestational age at delivery, caesarean section and neonatal
intensive care unit admission.
Model 3 is Model 2 further adjusted for third-trimester EPDS scores.
Table 3
Likelihood of women with a diagnosis of gestational diabetes mellitus be-
longing to the group with postpartum depressive symptomatology in logistic
regression models performed in the subgroup of women with complete ﬁrst-
trimester EPDS data (n=505).
Odds ratio 95% Conﬁdence interval p-value
Unadjusted 2.00 0.99–4.04 0.053
Model 1 1.82 0.86–3.87 0.117
Model 4 2.34 1.06–5.17 0.036
Model 5 2.43 1.05–5.62 0.039
Model 1 is adjusted for maternal age at delivery and BMI in the ﬁrst trimester.
Model 4 is Model 1 further adjusted for ﬁrst-trimester EPDS scores.
Model 5 is Model 4 further adjusted for third-trimester EPDS scores.
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factor for PPD (O'Hara and McCabe, 2013). From the point of view of
physiological mechanisms, abnormal glucose metabolism might par-
tially induce dysregulation of the hypothalamic–pituitary–adrenal axis
and increase cytokine-mediated inﬂammatory responses, which are
considered to be associated with depression (Moulton et al., 2015).
Such changes might lead, for example, to decreased serotonin produc-
tion in the central nervous system (Moulton et al., 2015). This hy-
pothesis is partly supported by previous evidence of a link between
insulin resistance and depression (Kan et al., 2013): this ﬁnding sug-
gests at least a partial contribution of direct physiological mechanisms,
considering that insulin resistance is not associated with a relevant
psychological burden, as is the case in overt diabetes. In addition,
chronic insulin resistance at some level has been suggested to con-
tribute to the development of GDM (Buchanan and Xiang, 2005), which
in turn was associated with PPDS in our study.
4.4. Strengths and limitations
In the attrition analyses, we detected no diﬀerences in BMI in the
ﬁrst trimester or maternal age at delivery between women excluded
from the analyses and our ﬁnal sample. Thus, the ﬁnal sample can be
considered to be representative of the whole extracted sample.
Furthermore, the availability of additional measures of depressive
symptomatology during pregnancy (in the third trimester for the whole
sample, and in both the ﬁrst and third trimesters for the sub-sample)
allowed us to control for the possible role of earlier-onset depressive
symptomatology, which is a strength of this study. An additional
strength is the explicitly deﬁned OGTT to identify GDM; this approach
is comparable with the testing recommended by the IADPSG panel, and
uses similar thresholds and analogous procedures (Coustan et al.,
2010).
Some limitations need to be taken into consideration while inter-
preting the ﬁndings of this study.
The participation rate in the KuBiCo study is relatively low (37%),
possibly due to the long duration of the whole study (approximately 19
years). Thus, even though all the women who were expected to give
birth at Kuopio University Hospital, with no exclusions, were invited to
participate in the study, the presence of a selection bias cannot be ruled
out. Furthermore, having access to measurements of glycated hae-
moglobin would have allowed undiagnosed cases of pre-pregnancy
diabetes to be detected, and would thus have improved the precision of
this study. However, adjusting multivariable models for BMI in the ﬁrst
trimester, a variable very likely to correlate strongly with pre-preg-
nancy diabetes, did not alter our ﬁnal observations. Thus, it is unlikely
that undiagnosed pre-pregnancy diabetes biased our ﬁndings.
Additionally, information on the clinical diagnoses of PPD would have
further supplemented information derived from the EPDS questionnaire
to identify PPDS. Nevertheless, the utilized EPDS questionnaire is a
well-established measure for investigating PPDS (Cox et al., 1987).
5. Conclusions
This study suggests that GDM is associated with a higher likelihood
of PPDS, irrespective of depressive symptomatology during pregnancy.
Future studies should investigate whether these women would beneﬁt
from a closer follow-up and possible supportive interventions during
pregnancy and the postpartum period to prevent PPDS. Furthermore,
the underlying mechanism of this association remains to be explored. It
would be beneﬁcial to resolve whether the psychological burden re-
lated to the GDM diagnosis is a signiﬁcant part of these mechanisms. If
this is the case, adopting new diagnostic criteria for GDM, which would
potentially increase the prevalence of GDM, would simultaneously in-
crease the prevalence of PPDS.
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